Overview The Senzime Next-Generation TetraGraph® is a quantitative neuromuscular monitor using electromyography (EMG) technology to provide real‑time Train‑of‑Four (TOF), Post‑Tetanic Count (PTC) and Single Twitch (ST) measurements. Intended for perioperative and critical care workflows, TetraGraph® offers software-driven analysis and clear visual trends to assist clinicians in optimizing neuromuscular blocking agent dosing, evaluating intubation readiness and guiding timely reversal and recovery.
Key Features - Quantitative neuromuscular monitoring based on EMG signals
- Real‑time TOF, PTC and ST measurements with trend visualization
- Level‑of‑Block Gauge™ for intuitive assessment of blockade depth
- Advanced algorithms for signal optimization and workflow support
- Portable, clinician‑focused form factor with flexible mounting options
- Connectivity options for external multiparameter monitors; EHR integration varies by configuration
- Compatible sensors: TetraSens (adult) and TetraSens Pediatric (FDA‑cleared for infants to adolescents)
- Designed to support clinical decision‑making and adherence to quantitative monitoring guidelines
Technical specifications - Technology: Electromyography (EMG)–based quantitative neuromuscular monitoring
- Measurements: Train‑of‑Four (TOF), Post‑Tetanic Count (PTC), Single Twitch (ST)
- Visualization: Level‑of‑Block Gauge™ for trend and depth assessment
- Software: Advanced analysis algorithms for signal quality, automation and workflow integration
- Design: Portable unit with multiple mounting and placement options for operating room and perioperative settings
- Connectivity: Interfaces to external multiparameter monitors; EHR connectivity dependent on system configuration
- Sensor compatibility: TetraSens (adult) and TetraSens Pediatric (FDA‑cleared for infants to adolescents)
- Clinical use: Supports perioperative neuromuscular monitoring to optimize dosing of neuromuscular blocking agents, assess intubation readiness and guide reversal and recovery